The ethics of phase I trials of biologic agents

被引：2
|
作者：
Hanauer, Stephen B.
机构：
[1] SB Hanauer is Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology.,
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2008年 / 5卷 / 10期
关键词：
D O I：
10.1038/ncpgasthep1259
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [31] Palliative care: A supportive adjunct to pediatric phase I clinical trials for anticancer agents?
    Ulrich, CM
    Grady, C
    Wendler, D
    PEDIATRICS, 2004, 114 (03) : 852 - 855
  • [32] Two-stage dose finding for cytostatic agents in phase I oncology trials
    Yin, Guosheng
    Zheng, Shurong
    Xu, Jiajing
    STATISTICS IN MEDICINE, 2013, 32 (04) : 644 - 660
  • [33] Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials
    Basu, B.
    Vitfell-Pedersen, J.
    Garcia, V. Moreno
    Puglisi, M.
    Tjokrowidjaja, A.
    Shah, K.
    Malvankar, S.
    Anghan, B.
    de Bono, J. S.
    Kaye, S. B.
    Molife, L. R.
    Banerji, U.
    ONCOLOGY, 2012, 83 (04) : 177 - 182
  • [34] Patients in phase I trials of anti cancer agents in Japan: Motivation, comprehension and expectations
    Itoh, K
    Sasaki, Y
    Fujii, H
    Ohtsu, T
    Wakita, H
    Igarashi, T
    Abe, K
    BRITISH JOURNAL OF CANCER, 1997, 76 (01) : 107 - 113
  • [35] Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents
    Fan, Shenghua Kelly
    Venook, Alan P.
    Lu, Ying
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (03) : 509 - 523
  • [36] A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents
    Braun, Thomas M.
    Wang, Shufang
    BIOMETRICS, 2010, 66 (03) : 805 - 812
  • [37] What I should do before considering biologic agents
    Willermain, F.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [38] Phase I trials of pemetrexed
    Fossella, FV
    Gatzemeier, U
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 8 - 16
  • [39] Extrapolating the speed of psoriasis clearance: A comparative analysis of biologic agents in clinical trials
    Pfau, Creighton
    Lovell, Katie K.
    Feldman, Steven R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1223 - 1224
  • [40] EVALUATING BIOLOGIC AGENTS IN RHEUMATOID-ARTHRITIS - A FRAMEWORK FOR CLINICAL-TRIALS
    STRAND, V
    SCOTT, DL
    PANAYI, GS
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (08) : 1390 - 1392
12345